Ibrutinib-resistant CLL: unwanted and unwonted!
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood-2017-01-761536
Abstract: In this issue of Blood, Ahn et al find intriguing clinical and molecular differences between early and late relapsing patients in a phase 2 trial of chronic lymphocytic leukemia (CLL) treated with ibrutinib.1 read more here.
Keywords: resistant cll; cll; ibrutinib resistant; unwanted unwonted ... See more keywords